TG Therapeutics: Peers

The FY2025 (Dec) proxy of TG Therapeutics names 17 peer companies for pay. Among TG Therapeutics and these peers, CEO pay was the highest of 10 and total shareholder return was 9th highest of 10.

1st highest of 10in TG Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:

$6.9M$25.6M

9th highest of 10in TG Therapeutics and its pay peers, FY2025 (Dec) by total shareholder return:

$17$524

Pay peer group, FY2025 (Dec) proxy

Halozyme Therapeutics
Madrigal Pharmaceuticals
BridgeBio Pharma
INSMED
Ionis Pharmaceuticals
Ultragenyx Pharmaceutical
Krystal Biotech
Adma Biologics
Neurocrine Biosciences
Acadia PharmaceuticalsNot disclosedNot disclosed
Amicus Therapeutics, Inc.Not disclosedNot disclosed
Apellis Pharmaceuticals, Inc.Not disclosedNot disclosed
Axsome TherapeuticsNot disclosedNot disclosed
Blueprint Medicines CorporationNot disclosedNot disclosed
Corcept TherapeuticsNot disclosedNot disclosed
SpringWorks TherapeuticsNot disclosedNot disclosed
VericelNot disclosedNot disclosed
17 companies

Changes by year

FY2025 (Dec) proxy

FY2024 (Dec) proxy

  • RemovedAdaptive Biotechnologiespay peer group
  • RemovedAurina Pharmaceuticals Inc.pay peer group
  • RemovedEQRX, Inc.pay peer group
  • RemovedImmunoGen, Inc.pay peer group
  • RemovedMirati Therapeutics, Inc.pay peer group
  • RemovedReata Pharmaceuticals, Inc.pay peer group
  • RemovedSage Therapeutics, Inc.pay peer group

FY2023 (Dec) proxy

  • RemovedAllakos Incpay peer group
  • RemovedBluebird bio, Incpay peer group
  • RemovedBridgeBio Pharmapay peer group
  • RemovedChemoCentryx, Incpay peer group
  • RemovedHeron Therapeutics, Incpay peer group
  • RemovedKodiak Sciences, Incpay peer group
  • RemovedUrogen Pharma Ltdpay peer group
  • RemovedY-Mabs Therapeutics, Inc.pay peer group

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.